UCB PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
UCB PHARMA
Largest movements
- Financial fixed assets +€3.82bn
up €3.82bn (+31.3%), from €12.20bn to €16.03bn
- Receivables within one year +€333.5m
up €333.5m (+16.4%), from €2.03bn to €2.36bn
of which Trade receivables: +€181.5m
- Profit (loss) carried forward +€3.38bn
up €3.38bn (+79.3%), from €4.27bn to €7.65bn
- Trade debts +€764.6m
up €764.6m (+78.2%), from €977.8m to €1.74bn
- Reserves +€455.5m
up €455.5m (+140.1%), from €325.1m to €780.6m
of which Non-distributable reserves: +€455.9m
- Short-term financial debts -€292.9m
down €292.9m (-96.0%), from €305.1m to €12.3m
of which Other loans: -€275.2m
- Financial income +€3.64bn
up €3.64bn (+918.8%), from €395.8m to €4.03bn
of which Non-recurring financial income: +€3.82bn
- Services and other goods +€904.2m
up €904.2m (+27.2%), from €3.32bn to €4.22bn
- Turnover +€411.2m
up €411.2m (+9.8%), from €4.21bn to €4.62bn
- Financial charges -€204.4m
down €204.4m (-61.5%), from €332.5m to €128.1m
of which Financial charges: -€182.0m
- Other operating income +€162.7m
up €162.7m (+11.6%), from €1.40bn to €1.56bn
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €16,414,794,946 | €20,742,385,083 | +€4.33bn | +26.4% |
| Fixed assets | 21/28 | €13,186,810,614 | €17,109,044,394 | +€3.92bn | +29.7% |
| Intangible fixed assets | 21 | €8,837,507 | €8,381,273 | -€456,234 | -5.2% |
| Tangible fixed assets | 22/27 | €975,353,777 | €1,075,264,999 | +€99.9m | +10.2% |
| Land and buildings | 22 | €203,674,814 | €412,941,560 | +€209.3m | +102.7% |
| Plant, machinery and equipment | 23 | €107,767,700 | €282,713,167 | +€174.9m | +162.3% |
| Furniture and vehicles | 24 | €4,085,780 | €6,692,369 | +€2.6m | +63.8% |
| Other tangible fixed assets | 26 | €9,701,522 | €8,031,985 | -€1.7m | -17.2% |
| Assets under construction and advance payments | 27 | €650,123,961 | €364,885,918 | -€285.2m | -43.9% |
| Financial fixed assets | 28 | €12,202,619,330 | €16,025,398,122 | +€3.82bn | +31.3% |
| Affiliated companies | 280/1 | €12,202,619,330 | €16,025,398,122 | +€3.82bn | +31.3% |
| Participating interests | 280 | €12,202,619,330 | €16,025,398,122 | +€3.82bn | +31.3% |
| Current assets | 29/58 | €3,227,984,332 | €3,633,340,689 | +€405.4m | +12.6% |
| Stocks and contracts in progress | 3 | €1,084,547,748 | €1,153,698,655 | +€69.2m | +6.4% |
| Stocks | 30/36 | €1,084,547,748 | €1,153,698,655 | +€69.2m | +6.4% |
| Raw materials and consumables | 30/31 | €123,261,918 | €172,798,849 | +€49.5m | +40.2% |
| Work in progress | 32 | €5,629,357 | €4,188,698 | -€1.4m | -25.6% |
| Finished goods | 33 | €955,622,258 | €976,699,490 | +€21.1m | +2.2% |
| Goods purchased for resale | 34 | €34,215 | €11,618 | -€22,597 | -66.0% |
| Amounts receivable within one year | 40/41 | €2,029,812,283 | €2,363,356,460 | +€333.5m | +16.4% |
| Trade receivables | 40 | €1,186,239,719 | €1,367,717,967 | +€181.5m | +15.3% |
| Other amounts receivable | 41 | €843,572,564 | €995,638,493 | +€152.1m | +18.0% |
| Cash at bank and in hand | 54/58 | €11,059,144 | €7,874,572 | -€3.2m | -28.8% |
| Deferred charges and accrued income | 490/1 | €102,565,157 | €108,411,002 | +€5.8m | +5.7% |
| Total equity and liabilities | 10/49 | €16,414,794,946 | €20,742,385,083 | +€4.33bn | +26.4% |
| Equity | 10/15 | €12,395,168,174 | €16,234,819,937 | +€3.84bn | +31.0% |
| Contributions | 10/11 | €7,804,773,810 | €7,804,773,810 | = | 0.0% |
| Capital | 10 | €7,804,773,798 | €7,804,773,798 | = | 0.0% |
| Issued capital | 100 | €7,804,773,798 | €7,804,773,798 | = | 0.0% |
| Outside capital | 11 | €12 | €12 | = | 0.0% |
| Share premium | 1100/10 | €12 | €12 | = | 0.0% |
| Reserves | 13 | €325,137,360 | €780,643,687 | +€455.5m | +140.1% |
| Non-distributable reserves | 130/1 | €324,581,469 | €780,480,362 | +€455.9m | +140.5% |
| Legal reserve | 130 | €324,578,487 | €780,477,381 | +€455.9m | +140.5% |
| Other | 1319 | €2,982 | €2,981 | -€1 | 0.0% |
| Tax-exempt reserves | 132 | €555,891 | €163,325 | -€392,566 | -70.6% |
| Profit (loss) carried forward | 14 | €4,265,257,004 | €7,649,402,440 | +€3.38bn | +79.3% |
| Provisions and deferred taxes | 16 | €87,563,574 | €136,487,956 | +€48.9m | +55.9% |
| Provisions for liabilities and charges | 160/5 | €87,159,859 | €136,215,097 | +€49.1m | +56.3% |
| Major repairs and maintenance | 162 | €17,010,668 | €22,804,836 | +€5.8m | +34.1% |
| Environmental obligations | 163 | €19,727,779 | €21,257,825 | +€1.5m | +7.8% |
| Other liabilities and charges | 164/5 | €50,421,412 | €92,152,436 | +€41.7m | +82.8% |
| Deferred taxes | 168 | €403,715 | €272,859 | -€130,856 | -32.4% |
| Amounts payable | 17/49 | €3,932,063,198 | €4,371,077,190 | +€439.0m | +11.2% |
| Amounts payable after more than one year | 17 | €2,113,463,674 | €2,085,984,545 | -€27.5m | -1.3% |
| Financial debts | 170/4 | €2,103,864,003 | €2,077,858,716 | -€26.0m | -1.2% |
| Other loans | 174 | €2,103,864,003 | €2,077,858,716 | -€26.0m | -1.2% |
| Other amounts payable | 178/9 | €9,599,671 | €8,125,829 | -€1.5m | -15.4% |
| Amounts payable within one year | 42/48 | €1,779,243,837 | €2,265,106,332 | +€485.9m | +27.3% |
| Financial debts | 43 | €305,148,846 | €12,277,015 | -€292.9m | -96.0% |
| Credit institutions | 430/8 | €19,636,424 | €1,959,854 | -€17.7m | -90.0% |
| Other loans | 439 | €285,512,422 | €10,317,161 | -€275.2m | -96.4% |
| Trade debts | 44 | €977,816,973 | €1,742,403,711 | +€764.6m | +78.2% |
| Suppliers | 440/4 | €977,816,973 | €1,742,403,711 | +€764.6m | +78.2% |
| Taxes, remuneration and social security | 45 | €102,232,452 | €72,669,345 | -€29.6m | -28.9% |
| Taxes | 450/3 | €66,223,522 | €30,491,539 | -€35.7m | -54.0% |
| Remuneration and social security | 454/9 | €36,008,930 | €42,177,806 | +€6.2m | +17.1% |
| Other amounts payable | 47/48 | €394,045,566 | €437,756,261 | +€43.7m | +11.1% |
| Accrued charges and deferred income | 492/3 | €39,355,687 | €19,986,313 | -€19.4m | -49.2% |
| Operating income | 70/76A | €5,877,730,993 | €6,225,012,057 | +€347.3m | +5.9% |
| Turnover | 70 | €4,211,459,762 | €4,622,639,386 | +€411.2m | +9.8% |
| Change in stocks of work in progress, finished goods and contracts in progress | 71 | €253,596,575 | €19,636,573 | -€234.0m | -92.3% |
| Own construction capitalised | 72 | €15,961,178 | €23,382,685 | +€7.4m | +46.5% |
| Other operating income | 74 | €1,396,660,758 | €1,559,334,922 | +€162.7m | +11.6% |
| Non-recurring operating income | 76A | €52,720 | €18,491 | -€34,229 | -64.9% |
| Operating charges | 60/66A | €4,850,272,577 | €5,890,341,974 | +€1.04bn | +21.4% |
| Goods for resale, raw materials and consumables | 60 | €1,174,006,845 | €1,213,424,871 | +€39.4m | +3.4% |
| Purchases | 600/8 | €1,180,923,323 | €1,282,356,693 | +€101.4m | +8.6% |
| Change in stocks: decrease (increase) | 609 | -€6,916,478 | -€68,931,822 | -€62.0m | -896.6% |
| Services and other goods | 61 | €3,318,475,942 | €4,222,705,134 | +€904.2m | +27.2% |
| Remuneration, social security and pensions | 62 | €249,704,424 | €291,343,444 | +€41.6m | +16.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €55,173,823 | €75,848,337 | +€20.7m | +37.5% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €6,019,836 | €15,936,539 | +€9.9m | +164.7% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €24,459,101 | €24,677,930 | +€218,829 | +0.9% |
| Other operating charges | 640/8 | €22,552,544 | €26,656,894 | +€4.1m | +18.2% |
| Non-recurring operating charges | 66A | -€119,938 | €19,748,825 | +€19.9m | |
| Operating profit (loss) | 9901 | €1,027,458,416 | €334,670,083 | -€692.8m | -67.4% |
| Financial income | 75/76B | €395,842,562 | €4,032,822,809 | +€3.64bn | +918.8% |
| Recurring financial income | 75 | €388,171,324 | €210,044,017 | -€178.1m | -45.9% |
| Income from financial fixed assets | 750 | €216,408,476 | €109,996,974 | -€106.4m | -49.2% |
| Income from current assets | 751 | €44,856,935 | €17,039,645 | -€27.8m | -62.0% |
| Other financial income | 752/9 | €126,905,913 | €83,007,398 | -€43.9m | -34.6% |
| Non-recurring financial income | 76B | €7,671,238 | €3,822,778,792 | +€3.82bn | +49732.6% |
| Financial charges | 65/66B | €332,457,435 | €128,102,553 | -€204.4m | -61.5% |
| Recurring financial charges | 65 | €310,072,388 | €128,102,553 | -€182.0m | -58.7% |
| Debt charges | 650 | €143,931,731 | €112,504,489 | -€31.4m | -21.8% |
| Other financial charges | 652/9 | €166,140,657 | €15,598,064 | -€150.5m | -90.6% |
| Non-recurring financial charges | 66B | €22,385,047 | - | -€22.4m | |
| Profit (loss) for the period before taxes | 9903 | €1,090,843,543 | €4,239,390,339 | +€3.15bn | +288.6% |
| Transfer from deferred taxes | 780 | €130,856 | €130,855 | -€1 | 0.0% |
| Income taxes | 67/77 | €143,546,099 | -€130,570 | -€143.7m | |
| Taxes | 670/3 | €143,584,723 | €28,185,124 | -€115.4m | -80.4% |
| Tax adjustments and reversals of tax provisions | 77 | €38,624 | €28,315,694 | +€28.3m | +73211.1% |
| Profit (loss) for the period | 9904 | €947,428,300 | €4,239,651,764 | +€3.29bn | +347.5% |
| Transfer from tax-exempt reserves | 789 | €392,566 | €392,566 | = | 0.0% |
| Profit (loss) for the period to be appropriated | 9905 | €947,820,866 | €4,240,044,330 | +€3.29bn | +347.3% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.